Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide (Wegovy) is injected just beneath the skin, not into muscle, at one of three licensed sites: the abdomen, the outer thigh, or the upper arm. The site you choose can affect comfort and how consistently the medicine is absorbed, so the guidance is specific and worth understanding before your first dose. Like all GLP-1 weight-management injections, Wegovy is a prescription-only medicine; a prescriber assesses suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that as long as the needle goes under the skin somewhere, the location is irrelevant. That isn't quite right. Semaglutide is absorbed through subcutaneous tissue, and the rate and consistency of that absorption can vary depending on blood flow, fat-layer depth and, crucially, whether the tissue in that spot has already been used repeatedly. Injecting repeatedly into the same precise patch of skin can cause a condition called lipohypertrophy, small, firm fatty deposits that form under the skin. Medication injected into those areas absorbs less predictably, which can blunt the medicine's effect over time. Rotation isn't a minor housekeeping detail; it's part of how the treatment is designed to work reliably.
The NHS patient guidance on semaglutide is clear that injections should be rotated between and within sites. If you notice any unusual lumps, hardness or skin changes at an injection spot, tell your prescriber at the next review.
The three areas licensed for Wegovy injection are the abdomen, the outer thigh, and the upper arm. Each has practical considerations worth knowing.
The abdomen is the most popular choice for self-injection. Aim for the area around your belly button (roughly a hand-width away from the navel itself) rather than the navel or the belt line. There is usually enough subcutaneous tissue here to make injection straightforward, and it's easy to see and pinch the skin yourself.
The outer thigh works well too, particularly if you find the abdomen uncomfortable. The front or outer-front surface of the thigh (roughly mid-thigh) offers a good amount of subcutaneous tissue. Avoid the inner thigh, where the skin is thinner and blood vessels are closer.
The upper arm (the outer, fleshy part of the upper arm) is the trickiest to use for self-injection simply because it's harder to reach and pinch with one hand. Many people who use the arm site have a partner or carer give the injection, or they learn a specific technique. If you're self-injecting into the arm, practise the grip before your first attempt.
You can rotate freely between all three sites from week to week, and our guide on where to inject semaglutide walks through each zone with practical diagrams to help you plan your rotation. Within a single site, move at least a centimetre or two from the previous injection point each time. Keeping a simple mental note (or even a small rotation chart) of which spot you used last makes this easy to manage.
If you're new to injectable medicines, it's normal to feel a little anxious before the first dose. Most people find the pen far less uncomfortable than they expected, the needle is fine and short, designed for subcutaneous use.
Clean the skin with an alcohol swab and let it dry fully before injecting; wet skin can sting. Pinch a fold of skin gently between your thumb and forefinger, insert the pen at the angle shown in your Patient Information Leaflet, press the injection button, and hold it in place for the count shown in the leaflet (typically around ten seconds) before withdrawing. This pause allows the full dose to be delivered before the needle is removed.
Change the needle before every injection. Reusing needles causes them to blunt, which makes insertion more uncomfortable and increases the risk of skin trauma at the site. The leaflet that comes with your pen details all of this, and your prescriber or pharmacist can walk you through it at any point. If you've received the brown Wegovy pen, which corresponds to a specific dose in the titration schedule, the same site and technique guidance applies.
If you've ever wondered about the best time of day to take your dose, that's a separate but related question, timing and site are both part of building a good weekly routine.
Most people use the same two or three spots within each site over the course of months. Over time, skin changes can creep in without being immediately obvious. Look at and feel each site regularly, and if you're ever unsure whether you're targeting the right area, our detailed page on where semaglutide should be injected covers the boundaries of each recommended zone and what to avoid. Signs to mention at your next review include persistent redness, any hard or raised patch that doesn't resolve between injections, or unusual bruising.
Severe injection-site reactions (significant swelling, spreading redness or pain beyond normal tenderness) should be reported sooner rather than at a scheduled review. You can reach the nume team for aftercare support seven days a week.
Suspected side effects from any medicine can also be reported directly to the MHRA via the Yellow Card scheme, which allows patients and healthcare professionals to flag problems and helps the regulator monitor safety signals across the UK population.
For a broader picture of how Wegovy fits into a structured treatment plan, the Wegovy overview on our treatment pages covers eligibility, the titration schedule, and what clinical review at nume looks like. If you're at the stage of comparing costs across providers, it's worth understanding what a legitimate prescription service includes beyond the pen itself. When you're ready to take the next step, you can start your free consultation and have your answers reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.